Scrip
Dr Bruce Carter joins Immune Design
24 November 2009
Zoe Dann
Please Login to read the full article.
24 November 2009
Zoe Dann
zoe.dann@informa.com
Dr Bruce Carter has joined Immune Design as executive chairman. He has experience in biotechnology executive management, having formerly served as CEO of ZymoGenetics, US, and chief scientific officer of Novo Nordisk, Denmark.
Please Login to read the full article.
RELATED CONTENT
NEWS
- 2009 Scrip Awards celebrate industry's achievements
- US FDA senior staff appointments reflect consumer advocacy and regulatory expertise
- Wellcome Trust financing sets Kymab on course
- GENova Biotherapeutics causes concern as media blitz culminates in stock trading suspension – update
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
